{"id":"https://genegraph.clinicalgenome.org/r/126343e0-5132-41ab-bb67-b82edee5fd7av1.0","type":"EvidenceStrengthAssertion","dc:description":"The dystrophic epidermolysis bullosa (DEB) disorders can be divided into recessive (RDEB, MONDO:0009179) and dominant (DDEB, MONDO:0002529). The RDEB is the most severe form of epidermolysis bullosa (EB). It is caused by biallelic pathogenic variants in the collage VII gene COL7A1. Patients with RDEB have up to 50 fold increased incidence of cutaneous squamous cell carcinoma (SCC) (PMID: 26083672). Clinically, the risk of developing SCC appears to parallel the severity, extent of ulceration and scarring of the skin, which in turn correlates with loss of collagen VII expression and decreased or absent anchoring fibrils. Loss-of-function mutations in COL7A1 in RDEB patients lead to dermal-epidermal tissue separation as a consequence of impaired interactions with major dermal epidermal junction (DEJ) components. More than 700 COL7A1 recessive DEB-causing variants spanning the entire gene have been described for all forms of DEB. Homozygous loss of function variants from a large study on 152 Iranian families with 238 patients of DEB (PMID: 27899325) and a small study (PMID: 26864810) are recorded in this curation for genetic evidence (12 points). This gene-disease association is also supported by experimental evidence (6 points).  A knockdown shCOL7 SCC-IC1 cell line demonstrated loss of COL7 reduced differentiation, increased VEGF expression, angiogenesis and invasion in shCOL7 xenografts similar to that seen in RDEB patients (PMID: 26476432). COL7A1-null mice die too early to initiate cancer studies (PMID: 10523500). A collagen VII hypomorphic mouse, homozygous Col7a1flNeo/flNeo mice, as an immunocompetent animal model for DEB showed expression of collagen VII at about 10% of normal levels, and their phenotype closely resembled characteristics of severe human DEB, including mucocutaneous blistering, nail dystrophy, and mitten deformities of the extremities. Wildtype fibroblast injection restored Collagen VII deposition and function at the DEJZ (PubMed: 18382769). In addition, an ABEmax (adenine base editor) corrected endogenous COL7A1 in autologous cells [patient derived fibroblasts and induced pluripotent stem cells (iPSCs)] can restore normalized epithelial architecture via increased COL7 expression (PMID: 31437443). In summary, both genetic and extensive experimental evidence demonstrate that COL7A1 is definitely associated with autosomal recessively inherited Dystrophic Epidermolysis Bullosa (DEB), which is associated with increased risk of developing squamous cell carcinoma (SCC). This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/126343e0-5132-41ab-bb67-b82edee5fd7a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/940fac3e-2586-4d49-a6f3-db12e865cc65","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/940fac3e-2586-4d49-a6f3-db12e865cc65_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-06-20T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/940fac3e-2586-4d49-a6f3-db12e865cc65_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-06-20T21:25:11.268Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/940fac3e-2586-4d49-a6f3-db12e865cc65_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c7f2d70-d5d8-43e6-aac8-8a168e933b6f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9cbe4c6b-a8ad-46fc-bad8-2e331a508068","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9cbe4c6b-a8ad-46fc-bad8-2e331a508068_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9dda56b-f57e-44f4-a799-64961a67b425","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000094.4(COL7A1):c.425A>G (p.Lys142Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA128526"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/9c7f2d70-d5d8-43e6-aac8-8a168e933b6f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","rdfs:label":"4-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9dda56b-f57e-44f4-a799-64961a67b425"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Mutilating scarring of the hands and feet, corneal involvement, poor dentition","phenotypes":["obo:HP_0002860","obo:HP_0008066","obo:HP_0200041"],"previousTesting":false,"secondTestingMethod":"Next generation sequencing panels","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9cbe4c6b-a8ad-46fc-bad8-2e331a508068_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/9f3a679a-cacc-41a5-a0b3-26e1a812cd98_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63741842-4402-47c4-ad21-60456153a14c","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63741842-4402-47c4-ad21-60456153a14c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b5c4ba2-1ef6-4a01-998f-bc54bd6f4e4e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000094.4(COL7A1):c.565C>T (p.Gln189Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1070885"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/9f3a679a-cacc-41a5-a0b3-26e1a812cd98","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","rdfs:label":"16-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b5c4ba2-1ef6-4a01-998f-bc54bd6f4e4e"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002860","obo:HP_0008066","obo:HP_0200041"],"previousTesting":false,"secondTestingMethod":"Next generation sequencing panels","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/63741842-4402-47c4-ad21-60456153a14c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/d02af25b-e478-4ca1-bc45-dac0197bd7cf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/462d17bc-6690-47c4-a66e-14965457c3b9","type":"EvidenceLine","dc:description":"This variant was found in 5 unrelated families in west Iran, exclusively in Lurish ethinicity, and haplotype analysis suggested founder effect. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/462d17bc-6690-47c4-a66e-14965457c3b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","allele":{"id":"https://genegraph.clinicalgenome.org/r/9e2e249b-fc1b-4679-9510-e12c2b27890d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000094.3(COL7A1):c.4233del (p.Gly1412fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/587424"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/d02af25b-e478-4ca1-bc45-dac0197bd7cf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","rdfs:label":"55-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/9e2e249b-fc1b-4679-9510-e12c2b27890d"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Mutilating scarring of the hands and feet, corneal involvement, poor dentition","phenotypes":["obo:HP_0200041","obo:HP_0008066","obo:HP_0002860"],"previousTesting":false,"secondTestingMethod":"Next generation sequencing panels","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/462d17bc-6690-47c4-a66e-14965457c3b9_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/7bb1c044-f35c-4cd1-9aed-6a318bda05ca_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/293d13e6-5283-4bef-9f1b-fdec4a0b47e0","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/293d13e6-5283-4bef-9f1b-fdec4a0b47e0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26864810","allele":{"id":"https://genegraph.clinicalgenome.org/r/2d09a371-ee28-44a5-b167-3f1615eb2d01","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000094.4(COL7A1):c.5096C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA127196"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7bb1c044-f35c-4cd1-9aed-6a318bda05ca","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26864810","rdfs:label":"Case 2","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":0,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2d09a371-ee28-44a5-b167-3f1615eb2d01"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Denaturing gradient gel","phenotypes":["obo:HP_0001057","obo:HP_0008066","obo:HP_0001798"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/293d13e6-5283-4bef-9f1b-fdec4a0b47e0_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b912584b-8b39-455b-a955-a45102debc53_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff5be9d0-661e-4aca-a716-66d9c4640573","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff5be9d0-661e-4aca-a716-66d9c4640573_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","allele":{"id":"https://genegraph.clinicalgenome.org/r/ffb95af4-7bc3-4d0e-8e22-d009c338c680","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000094.4(COL7A1):c.4128delT","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/663385"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/b912584b-8b39-455b-a955-a45102debc53","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","rdfs:label":"54-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/ffb95af4-7bc3-4d0e-8e22-d009c338c680"},"firstTestingMethod":"Sanger sequencing","previousTesting":false,"secondTestingMethod":"Next generation sequencing panels","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/ff5be9d0-661e-4aca-a716-66d9c4640573_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/91ae3535-84d9-4236-857b-3b209c55e505_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96bb4b77-0d32-4af8-abd4-00649cbf20f5","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96bb4b77-0d32-4af8-abd4-00649cbf20f5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9e2a5ce-a08b-4406-81ef-d6e11382d6cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000094.4(COL7A1):c.553C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10602899"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/91ae3535-84d9-4236-857b-3b209c55e505","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","rdfs:label":"11-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9e2a5ce-a08b-4406-81ef-d6e11382d6cb"},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/96bb4b77-0d32-4af8-abd4-00649cbf20f5_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/940fac3e-2586-4d49-a6f3-db12e865cc65_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ea8de29-732f-45c8-9036-8b34349531aa_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","rdfs:label":"55","family":{"id":"https://genegraph.clinicalgenome.org/r/7ea8de29-732f-45c8-9036-8b34349531aa","type":"Family","rdfs:label":"55","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/d02af25b-e478-4ca1-bc45-dac0197bd7cf"}},"phenotypeFreeText":"Mutilating scarring of the hands and feet, corneal involvement, poor dentition","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002860","obo:HP_0200041","obo:HP_0008066"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/d02af25b-e478-4ca1-bc45-dac0197bd7cf"}},{"id":"https://genegraph.clinicalgenome.org/r/4da36432-4821-416a-b58a-de99264a2f62_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","rdfs:label":"11","family":{"id":"https://genegraph.clinicalgenome.org/r/4da36432-4821-416a-b58a-de99264a2f62","type":"Family","rdfs:label":"11","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/91ae3535-84d9-4236-857b-3b209c55e505"}},"phenotypeFreeText":"Mutilating scarring of the hands and feet, corneal involvement, poor dentition","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002860","obo:HP_0200041","obo:HP_0008066"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/91ae3535-84d9-4236-857b-3b209c55e505"}},{"id":"https://genegraph.clinicalgenome.org/r/2f43da47-9c10-4e28-a2e9-863fc328e35f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","rdfs:label":"16","family":{"id":"https://genegraph.clinicalgenome.org/r/2f43da47-9c10-4e28-a2e9-863fc328e35f","type":"Family","rdfs:label":"16","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9f3a679a-cacc-41a5-a0b3-26e1a812cd98"}},"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002860","obo:HP_0008066","obo:HP_0200041"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9f3a679a-cacc-41a5-a0b3-26e1a812cd98"}},{"id":"https://genegraph.clinicalgenome.org/r/5b831f45-31da-4f8c-aff0-4171c4eefe95_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","rdfs:label":"54","family":{"id":"https://genegraph.clinicalgenome.org/r/5b831f45-31da-4f8c-aff0-4171c4eefe95","type":"Family","rdfs:label":"54","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b912584b-8b39-455b-a955-a45102debc53"}},"phenotypeFreeText":"Mutilating scarring of the hands and feet, corneal involvement, poor dentition","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0008066","obo:HP_0002860","obo:HP_0200041"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b912584b-8b39-455b-a955-a45102debc53"}},{"id":"https://genegraph.clinicalgenome.org/r/d3be3985-d0fa-47d6-80a4-bbf032f0ce89_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27899325","rdfs:label":"4","family":{"id":"https://genegraph.clinicalgenome.org/r/d3be3985-d0fa-47d6-80a4-bbf032f0ce89","type":"Family","rdfs:label":"4","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9c7f2d70-d5d8-43e6-aac8-8a168e933b6f"}},"phenotypeFreeText":"Mutilating scarring of the hands and feet, corneal involvement, poor dentition","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002860","obo:HP_0008066","obo:HP_0200041"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9c7f2d70-d5d8-43e6-aac8-8a168e933b6f"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/940fac3e-2586-4d49-a6f3-db12e865cc65_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/940fac3e-2586-4d49-a6f3-db12e865cc65_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bbb54467-8c18-409a-9660-e1e650f1f379","type":"EvidenceLine","dc:description":"A hypomorphic COL7A1 mouse model, Col7a1flNeo/flNeo, with many features of human RDEB. Col7a1flNeo allele is an allele with an 11-kb genomic fragment of Col7a1 gene replaced with a targeting construct. The construct contains a phosphoglycerate kinase promoterâ€“driven neomycin phosphotransferase expression cassette (PGK-Neo cassette) and 2 flanking Frt sites that allow its Flp-mediated removal.  This mouse model demonstrated reduced COL7a1 expression of 10% normal; restored collagen VII deposition and function at teh DEJZ (dermal epidermal junction zone). ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55a0daf5-5539-4ec8-8b22-ee9b812f7f09","type":"Finding","dc:description":"This hypomorphic mouse model expressed collagen VII at about 10% of normal level and showed similar phenotypes of mucocutaneous blastering, nail dystrophy and mitten deformities of the extremities as well as growth retardation. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18382769","rdfs:label":"Mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2c6caa77-9b94-44fc-84ec-74f8522ac288","type":"EvidenceLine","dc:description":"ABEmax mRNA and sgRNAs were delivered to primary patient fibroblasts, western blot analysis showed restored full length C7 expression in treated cell lysates, as well restored normalized tissue architecture in 3D organotypic in vitro skin culture system. Homo variant patient","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b73f6df-b7e1-4162-b5dc-97228c30d44d","type":"Finding","dc:description":"Restored full length C7 expression in treated cell lysates, as well restored normalized tissue architecture in 3D organotypic in vitro skin culture system. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31437443","rdfs:label":"Western blot","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b2072eb3-f7f9-40dd-87f6-271c4f4b1681","type":"EvidenceLine","dc:description":"ABEmax mRNA and sgRNAs were delivered to primary patient fibroblasts, western blot analysis showed restored full length C7 expression in treated cell lysates, as well restored normalized tissue architecture in 3D organotypic in vitro skin culture system. compound het patient","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2f2c4b5-0d73-4312-a7b0-1558b0d359ec","type":"Finding","dc:description":"Restored full length C7 expression in treated cell lysates, as well restored normalized tissue architecture in 3D organotypic in vitro skin culture system","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31437443","rdfs:label":"Western blot","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/be1ba2df-907e-40cd-85d0-429021628ef5","type":"EvidenceLine","dc:description":"3D culture of corrected cells promoted normalized epithelial layer attachment in vitro. ABE patient fibroblast cells  restored structural integrity without epithelial layer detachment that  uncorrected cells have.  ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a6f28fc-6bfa-4589-a540-70f8d01eb1c7","type":"Finding","dc:description":"ABE patient fibroblast cells  improved structural integrity without epithelial layer detachment. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31437443","rdfs:label":"3D epithelial tissue attachment assay","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/940fac3e-2586-4d49-a6f3-db12e865cc65_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/936cf43d-f60f-483c-a44f-793dc3d129ab","type":"EvidenceLine","dc:description":"Media from SCC-IC1 shCOL7 cells (Loss of COL7 expression) increased tube formation in human umbilical vein endothelial cells (HUVECs) and increased VEGF expression. Which explain increased angiogenesis in the context of loss of Col7.  ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0764a693-63cd-436b-a79f-359564ec012c","type":"FunctionalAlteration","dc:description":"Media from SCC-IC1 shCOL7 cells increased tube formation in human umbilical vein endothelial cells (HUVECs). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26476432","rdfs:label":"An endothelial tube formation assay"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6012353c-8176-4ac4-a640-04e12629bf24","type":"EvidenceLine","dc:description":"shCOL7 knockdown cutaneous SCC cell line (SCC-IC1) showed more vascular on shCOL7 xenografts, increased invasion. RDEB patient scarred skin was also more vascular than normal skin.  ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b33d493c-0d4f-4787-93ca-fe8e2946745f","type":"FunctionalAlteration","dc:description":"The shRNA shCOL7_3 statistically significantly reduced expression of Col7 in SCC-IC1. The shCOL7 xenografts were more vascular, with an increased number of tortuous blood vessels (BV) and increased invasion.  RDEB patient scarred skin was also more vascular than normal skin.  ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26476432","rdfs:label":"Human Angiogenesis Proteome Array"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/940fac3e-2586-4d49-a6f3-db12e865cc65_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/044399e6-887b-4692-9677-387ee4956d88","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba24db20-1492-44d5-abbb-4f8e7844c341","type":"Finding","dc:description":"Patient carries compound heterzygous variants, NM_000094.4(COL7A1):c.1573C>T; NM_000094.3(COL7A1):c.2005C>T (p.Arg669Ter) showed no COL7A1 expression in patient derived fibroblast cell culture. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31437443","rdfs:label":"Western blot","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9539e9ec-6d7f-4d8a-971b-ba0edfcd92c7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3734ca92-9a0e-496b-8db1-03e03b2a2b06","type":"Finding","dc:description":"Patient carries homozygous variants, NM_000094.4(COL7A1):c.553C>T, showed now COL7A1 expression in patient derived  fibroblast cell culture. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31437443","rdfs:label":"Western blot","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":4599,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ZSvtUbU-7U8","type":"GeneValidityProposition","disease":"obo:MONDO_0009179","gene":"hgnc:2214","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_940fac3e-2586-4d49-a6f3-db12e865cc65-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}